Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy (AVERT)
This study is currently recruiting participants.
Verified March 2012 by University of Vermont
Sponsor:
University of Vermont
Collaborators:
Mayo Clinic
Comprehensive Cancer Center of Wake Forest University
Information provided by (Responsible Party):
Steven Ades, University of Vermont
ClinicalTrials.gov Identifier:
NCT00970905
First received: August 25, 2009
Last updated: March 30, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |